N/A
Completed N=24
Oral Immunotherapy for Peanut and Mammalian Meat Allergies
Food Hypersensitivity
Source: ClinicalTrials.gov NCT02350660 ↗
Enrolled (actual)
24
Serious AEs
0.0%
Results posted
Nov 2020
Primary outcomePrimary: The Level of Allergen Consumed Post-oral Immunotherapy — 6; 300 milligrams
Summary
Pilot study to assess the effect of oral immunotherapy on specific Immunoglobulin E (IgE) levels and antigen consumption in two distinct food allergies.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY The Level of Allergen Consumed Post-oral Immunotherapy |
6; 300 | — |
Eligibility Criteria
Inclusion Criteria
- Presence or absence of specific IgE to alpha-gal or peanut
Exclusion Criteria
- History of severe anaphylaxis
- allergy to cow's milk protein
Data sourced from ClinicalTrials.gov (NCT02350660). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.